Mannose shows antitumour properties against lung cancer via inhibiting proliferation, promoting cisplatin‑mediated apoptosis and reducing metastasis.

作者: Youyu Wang , Shenglong Xie , Bin He

DOI: 10.3892/MMR.2020.11354

关键词: Cancer researchChemistryCisplatinMannoseProtein kinase BViability assayCell cycleApoptosisCellPI3K/AKT/mTOR pathway

摘要: It has been reported that mannose exerts antitumour effects against certain types of cancer. The present study was designed to evaluate whether exerted potential anticancer on A549 and H1299 non‑small cell lung cancer (NSCLC) cells in vitro, which not previously. A Cell Counting Kit‑8 viability assay used assess the antiproliferative NSCLC cells. Flow cytometry‑based methods were cycle distribution cisplatin‑mediated apoptosis Transwell migration invasion assays conducted examine could inhibit invasive abilities PI3K/AKT ERK signalling pathways explored through western blot analysis assessing expression phosphorylated (p)‑AKT p‑ERK1/2. found showed vitro by inhibiting proliferation, inducing G0/G1 arrest, promoting cisplatin‑induced decreasing abilities. These data indicate properties suggest application mannose‑based therapies treat NSCLC.

参考文章(24)
Yujie Zhao, Alex A. Adjei, New strategies to develop new medications for lung cancer and metastasis Cancer and Metastasis Reviews. ,vol. 34, pp. 265- 275 ,(2015) , 10.1007/S10555-015-9553-5
Qun‐Ying Hong, Guo-Ming Wu, Gui‐Sheng Qian, Cheng‐Ping Hu, Jian‐Ying Zhou, Liang‐An Chen, Wei‐Min Li, Shi‐Yue Li, Kai Wang, Qi Wang, Xiao‐Ju Zhang, Jing Li, Xin Gong, Chun‐Xue Bai, Lung Cancer Group of the Chinese Thoracic Society; Chinese Alliance Against Lung Cancer, None, Prevention and management of lung cancer in China Cancer. ,vol. 121, pp. 3080- 3088 ,(2015) , 10.1002/CNCR.29584
E. Deutsch, C. Le Péchoux, L. Faivre, S. Rivera, Y. Tao, J.-P. Pignon, M. Angokai, R. Bahleda, D. Deandreis, E. Angevin, C. Hennequin, B. Besse, A. Levy, J.-C. Soria, Phase I trial of everolimus in combination with thoracic radiotherapy in non-small-cell lung cancer Annals of Oncology. ,vol. 26, pp. 1223- 1229 ,(2015) , 10.1093/ANNONC/MDV105
Paul Dent, Crosstalk between ERK, AKT, and cell survival Cancer Biology & Therapy. ,vol. 15, pp. 245- 246 ,(2014) , 10.4161/CBT.27541
Claudia Fumarola, Mara A. Bonelli, Pier Giorgio Petronini, Roberta R. Alfieri, Targeting PI3K/AKT/mTOR pathway in non small cell lung cancer. Biochemical Pharmacology. ,vol. 90, pp. 197- 207 ,(2014) , 10.1016/J.BCP.2014.05.011
Rob A. Cairns, Isaac S. Harris, Tak W. Mak, Regulation of cancer cell metabolism Nature Reviews Cancer. ,vol. 11, pp. 85- 95 ,(2011) , 10.1038/NRC2981
Justin Sturge, S. Katrina Todd, Giolanta Kogianni, Afshan McCarthy, Clare M. Isacke, Mannose receptor regulation of macrophage cell migration Journal of Leukocyte Biology. ,vol. 82, pp. 585- 593 ,(2007) , 10.1189/JLB.0107053
Aurélie Cazet, Jonathan Charest, Daniel C. Bennett, Cecilia Lopez Sambrooks, Joseph N. Contessa, Mannose Phosphate Isomerase Regulates Fibroblast Growth Factor Receptor Family Signaling and Glioma Radiosensitivity PLOS ONE. ,vol. 9, ,(2014) , 10.1371/JOURNAL.PONE.0110345
M de la Fuente, A Hernanz, Enzymes of mannose metabolism in murine and human lymphocytic leukaemia British Journal of Cancer. ,vol. 58, pp. 567- 569 ,(1988) , 10.1038/BJC.1988.260